A REVIEW ON INFLAMMATORY BOWEL DISEASE

Authors

  • CHINMAY DEVIDAS DESHMUKH Department of Pharmacology, School of Pharmacy, Dr. VishwanathKarad MIT World Peace University, Pune, Maharashtra, India.

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i6.47124

Keywords:

Crohn’s disease, Inflammatory bowel disease, Chair syndrome, Fistula

Abstract

The gastrointestinal tract commonly known as the digestive tract is one of the most important canals in the body. It consists of the passage from mouth to anus including organs that help in the digestion. The food is taken into the mouth and all essential nutrients, and vitamins are absorbed from the digestive tract. The tract consists of important digestive organs such as the pharynx, esophagus, stomach, intestine, and rectum. Although the word gastrointestinal includes the entire tract, most commonly it is the stomach and intestine. The process of digestion is complex including a variety of minor processes. This includes mastication of food, mixing with saliva to form a bolus, mixing with various gastric enzymes to form chyme, mixing with intestinal, pancreatic and hepatic juices, absorption, and extraction, removal of water and fecal compaction and elimination. These processes are very disciplined, round-the-clock, and systematic. However, there may be chances of certain problems in this routine work such as infections, inflammation, irritation, acidity, or diseases. Constipation, diarrhea, inflammatory bowel disease (IBD), fissure, piles, fistulas, and hemorrhoids are some of the common. The smooth and easy process of digestion of food and elimination of waste is disturbed due to any of these diseases. Certain environmental factors, genetics, gender and age, smoking, chair syndrome, and geographical factors are the main things of the development of IBD. IBD causes prolonged digestive tract inflammation. There are various other underlying symptoms of the disease which are discussed in the article. The two types of this disease are ulcerative colitis and Crohn’s disease. There are possible complications of these diseases such as malnutrition, weight loss, colon cancer, fistula, perforation, bowel rupture, etc. If these are not managed well in advance, then it may lead to the death of the person. To know more about the disease, the present review is an attempt to focus on all possible causes, clinical presentation, diagnosis, complications, and management of IBD. The experimental induction models are also tried to discuss in the present article.

Downloads

Download data is not yet available.

References

Zatorski H, Sałaga M, Zielínska M, Fichna J. Genetic factors in pathogenesis, course and treatment of inflammatory bowel diseases. Postepy Hig Med Dosw (Online) 2015;69:335-44.

Abbas KF. Robin and Cotran’s Pathologic Basis of Disease. 7th ed. Philadelphia, PA: Saunders Publisher; 2009. p. 846-85.

Fakhoury M, Negrulj R, Mooranian A, Al-Salami H. Inflammatory bowel disease: Clinical aspects and treatments. J Inflamm Res 2014;7:113-20. doi: 10.2147/JIR.S65979, PMID 25075198

Ahuja V, Tandon RK. Inflammatory bowel disease: The Indian augury. Indian J Gastroenterol 2012;31:294-6. doi: 10.1007/s12664-012-0272- 3, PMID 23150035

Khosla SN, Girdhar NK, Lal S, Mishra DS. Epidemiology of ulcerative colitis in hospital and select general population of northern India. J Assoc Physicians India 1986;34:405-7. PMID 3771475

Makharia GK, Ramakrishna BS, Abraham P, Choudhuri G, Misra SP, Ahuja V, et al. Survey of inflammatory bowel diseases in India. Indian J Gastroenterol 2012;31:299-306. doi: 10.1007/s12664-012-0258-1,PMID 23073755

Wang S, Huang Y, Zhou C, Wu H, Zhao J, Wu L, et al. The role of autophagy and related microRNAs in inflammatory bowel disease. Gastroenterol Res Pract 2018;2018:7565076. doi: 10.1155/2018/7565076, PMID 30046303

Abraham C, Dulai PS, Vermeire S, Sandborn WJ. Lessons learned from trials targeting cytokine pathways in patients with inflammatory bowel diseases. Gastroenterology 2017;152:374-88.e4.

Vrakas K, Mountzouris C, Michalopoulos G, Karamanolis G, Papatheodoridis G, Tzathas C, et al. Intestinal bacteria composition and translocation of bacteria in inflammatory bowel disease. PLoS One 2017;2:e0170034.

Rizzello F, Spisni E, Giovanardi E, Imbesi V, Salice M, Alvisi P, et al. Implications of the westernized diet in the onset and progression of IBD. Nutrients 2019;11:1033. doi: 10.3390/nu11051033, PMID 31072001

Berardi RR. Inflammatory bowel disease. In: Textbook of Therapeutics-drug and Disease Management. 7th ed. United States: Lippincott Williams and Willkins; 2000. p. 483-502.

Abreu MT. The pathogenesis of inflammatory bowel disease: Translational implications for clinicians. Curr Gastroenterol Rep 2002;4:481-9. doi: 10.1007/s11894-002-0024-0, PMID 12441038

Strober W, Lúdvíksson BR, Fuss IJ. The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann Intern Med 1998;128:848-56. doi: 10.7326/0003- 4819-128-10-199805150-00009, PMID 9599198

Shanahan F. Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 2001;120:622-35. doi: 10.1053/gast.2001.22122

Tanaka S, Mitsui K, Shirakawa K, Tatsuguchi A, Nakamura T, Hayashi Y, et al. Successful retrieval of video capsule endoscopy retained at ileal stenosis of Crohn’s disease using double-balloon endoscopy. J Gastroenterol Hepatol 2006;21:922-3. doi: 10.1111/j.1440- 1746.2006.04120.x, PMID 16704551

Hruz P, Eckmann L. Innate immune defence: NOD2 and autophagy in the pathogenesis of Crohn’s disease. Swiss Med Wkly 2010;140:w13135. doi: 10.4414/smw.2010.13135, PMID 21213148

Paulsen SR, Huprich JE, Hara AK. CT enterography: Noninvasive evaluation of Crohn’s disease and obscure gastrointestinal bleed. Radiol Clin North Am 2007;45:303-15.

Geboes K. Histopathology of Crohn’s disease and ulcerative colitis. In: Satsangi J, Sutherland LR, editors. Inflammatory Bowel Diseases. 4th ed. New York: Churchill Livingstone; 2003. p. 255-76.

Kugathasan S, Saubermann LJ, Smith L, Kou D, Itoh J, Binion DG, et al. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Gut 2007;56:1696-705.

Hagar HH, El-Medany A, El-Eter E, Arafa M. Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats. Eur J Pharmacol 2007;554:69-77. doi: 10.1016/j.ejphar.2006.09.066, PMID 17112501

Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 1993;17:641-62.

Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods 2004;50:81-92. doi: 10.1016/j.vascn.2003.12.002, PMID 15385082

Published

07-06-2023

How to Cite

DESHMUKH, C. D. “A REVIEW ON INFLAMMATORY BOWEL DISEASE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 16, no. 6, June 2023, pp. 11-14, doi:10.22159/ajpcr.2023.v16i6.47124.

Issue

Section

Review Article(s)